Long-term metformin use may improve clinical outcomes in diabetic patients with non-alcoholic steatohepatitis and bridging fibrosis or compensated cirrhosis.

Saved in:
Bibliographic Details
Title: Long-term metformin use may improve clinical outcomes in diabetic patients with non-alcoholic steatohepatitis and bridging fibrosis or compensated cirrhosis.
Authors: Vilar-Gomez E; Division of Gastroenterology and Hepatology, Indiana University School of Medicine, Indianapolis, Indiana., Vuppalanchi R; Division of Gastroenterology and Hepatology, Indiana University School of Medicine, Indianapolis, Indiana., Desai AP; Division of Gastroenterology and Hepatology, Indiana University School of Medicine, Indianapolis, Indiana., Gawrieh S; Division of Gastroenterology and Hepatology, Indiana University School of Medicine, Indianapolis, Indiana., Ghabril M; Division of Gastroenterology and Hepatology, Indiana University School of Medicine, Indianapolis, Indiana., Saxena R; Department of Pathology, Indiana University School of Medicine, Indianapolis, Indiana., Cummings OW; Department of Pathology, Indiana University School of Medicine, Indianapolis, Indiana., Chalasani N; Division of Gastroenterology and Hepatology, Indiana University School of Medicine, Indianapolis, Indiana.
Source: Alimentary pharmacology & therapeutics [Aliment Pharmacol Ther] 2019 Aug; Vol. 50 (3), pp. 317-328. Date of Electronic Publication: 2019 Jun 03.
Publication Type: Journal Article
Journal Info: Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 8707234 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1365-2036 (Electronic) Linking ISSN: 02692813 NLM ISO Abbreviation: Aliment Pharmacol Ther Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Description
ISSN:1365-2036
DOI:10.1111/apt.15331